PLOD1 and polycystic ovary syndrome: This model has since been well characterized metabolically and exhibits a PCOS-like phenotype with hyperandrogenemia, increased LH activity, irregular cyclicity and abnormal glucose/insulin tolerance while maintaining the same weight and BMI as the control population (18, 20, 21).